Aukera Therapeutics
Designing new classes of drugs to selectively target different branches of the mTOR pathway
Total raised
€483k
€482,533
Funding rounds
1
Investors
1
distinct backers
Active since
2022-02
latest 2022-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood11
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-21 | Other | €483k | BaseLaunch | View deal → |
Investors
1Related news
- BaseLaunch invests USD 1.5 million in three new startupsstartupticker.ch · 2022-02
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy